Patents by Inventor EMMANOUIL ZACHARIOUDAKIS

EMMANOUIL ZACHARIOUDAKIS has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Mitofusin activators and uses thereof
    Patent number: 11813268
    Abstract: Activators of mitofusins and their uses in treatment of diseases and disorders are disclosed.
    Type: Grant
    Filed: October 16, 2018
    Date of Patent: November 14, 2023
    Assignee: Albert Einstein College of Medicine
    Inventors: Evripidis Gavathiotis, Richard N. Kitsis, Nikolaos Biris, Emmanouil Zacharioudakis
  • MITOFUSIN ACTIVATORS AND USES THEREOF
    Publication number: 20200261469
    Abstract: Activators of mitofusins and their uses in treatment of diseases and disorders are disclosed.
    Type: Application
    Filed: October 16, 2018
    Publication date: August 20, 2020
    Inventors: Evripidis Gavathiotis, Richard N. Kitsis, Nikolaos Biris, Emmanouil Zacharioudakis
  • VISUAL DETECTION OF PLATINATED DNA LESIONS FROM A CLICKABLE CISPLATIN PROBE USED AS DIAGNOSTIC TOOL OR TO IDENTIFY SYNERGISTIC TREATMENTS
    Publication number: 20180355441
    Abstract: The present invention relates to a new compound for visualizing DNA-platinum crosslink, and its use as a research tool and in screening method for identifying candidate drug to be used in combination with platinating compounds such as cisplatin, carboplatin, and oxaliplatin. The project leading to this application has received funding from the European Research Council (ERC) under the European Union's Horizon 2020 research and innovation program (grant agreement No [647973]).
    Type: Application
    Filed: December 15, 2016
    Publication date: December 13, 2018
    Inventors: RAPHAEL RODRIGUEZ, EMMANOUIL ZACHARIOUDAKIS, LAVANIYA KUNALINGAM, ALEXANDRA BARTOLI, KYLE MILLER, POONAM AGARWAL